Searchable abstracts of presentations at key conferences in endocrinology

ea0045p16 | Diabetes | BSPED2016

An Audit of the Paediatric Diabetes Out Of Hours Advice Service using the Best Practice Tariff Criteria

Starr Emma , Quintela Ella , Denvir Louise , Sachdev Pooja

Background/Introduction: The Best Practice Tariff was introduced in 2012 in England and Wales to provide adequate funding and ensure quality care for all children with Diabetes. The tariff criteria states that units must provide “24 hour access to advice and support” including “24 hour expert advice to other healthcare professionals”. The aims of this audit were to: evaluate the Nottingham Children’s Hospital out of hours paediatric diabetes service, d...

ea0045p21 | Diabetes | BSPED2016

Efficacy and uptake of an education clinic integrated into an MDT clinic for children with type 1 diabetes

Quintela Ella , Drew Josephine , Denvir Louise , Randell Tabitha , Sachdev Pooja

Introduction: The Best Practice Tariff states that units must provide a structured education programme which should be ‘tailored to the child’s needs, both at the time of initial diagnosis and ongoing updates’. Traditionally, there has been poor uptake of our education sessions with attendance rates of 20% (range 0–30). Therefore, an integrated education clinic was introduced which combined education within a multidisciplinary (MDT) clinic session for ongoi...

ea0045p41 | Diabetes | BSPED2016

High HBA1c pathway for children and young people with poor glycaemic control: process and outcomes

Fradley Wayne , Sachdev Pooja , Randell Tabitha , Denvir Louise

Background: Children and Young People (C&YP) with poorly controlled diabetes are at increased risk of diabetic ketoacidosis (DKA) and long-term sequelae. There is no clear evidence about how best to manage them. NPDA data highlights that UK numbers are in decline, but still constitutes 21.3% of C&YP with diabetes. The high HbA1c pathway at Nottingham Children’s Hospital (NCH) aims to systematically identify and support C&YP with HbA1c >80 mmol/mol. It prov...

ea0094p304 | Adrenal and Cardiovascular | SFEBES2023

Assessment of adrenal incidentalomas: Benefits of a nurse-led clinic

Smith Robert , Marseden Louise , Delbene Leanne , Thomas Julia

Background: Adrenal incidentalomas (AI), the finding of asymptomatic adrenal lesion on unrelated imaging, represent an increasing number of endocrine referrals. In 2022, we introduced a nurse-led pathway to manage AI.Aim: To assess the cost savings and patient experience of a telephone nurse-led AI service at Musgrove Park Hospital.Methods: Records for patients seen in the AI clini...

ea0094p154 | Nursing Practice | SFEBES2023

Improving collaboration between endocrine patient support groups and the society for endocrinology

Breen Louise , Smith Vick , Okoro Grace , Turner Helen

Background: Patient Support Groups (PSG) play a key role in the support, education, research and training for patients and clinicians alike, as well as providing invaluable input to key documents e.g. Defining the Future of Endocrinology (DfE), highlighting the importance of a closer working relationship with SfE.About the PSG Network: Established in Sept 2021, the network includes representation from SfE affiliated PSG ...

ea0095p5 | Adrenal 1 | BSPED2023

Retrospective review of patients with 21-hydroxylase deficiency (21OHD) Congenital adrenal hyperplasia (CAH) in a tertiary children’s hospital

Riches Katherine , Abey Rose , Denvir Louise , Law James , Sachdev Pooja

Background: The most common form (90%) of CAH is 21-hydroxylase deficiency (21OHD). Management is with hydrocortisone ±fludrocortisone replacement while minimising side effects of androgen excess. Our aim was to review our CAH cohort and describe their characteristics, treatment regimens and growth.Methods: Retrospective data on height, weight, BMI, bone age and biochemical profiles was collected on 26 patients with...

ea0095p27 | Diabetes 1 | BSPED2023

Type 1 diabetes associated with primary sclerosing cholangitis and inflammatory bowel disease – a rare autoimmune combination

Shah Shilpa , Millar Sarinda , Gupte Girish , McLaughlin Louise

Introduction: Type 1 diabetes is an autoimmune condition resulting in insulin deficiency. Surveillance of other autoimmune disorders such as coeliac disease and hypothyroidism is common practice due to their higher co association. We describe a case of a 14 year old girl with 2 rarer autoimmune conditions; primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD)Case summary: A 14 year old girl presented ...

ea0095p29 | Diabetes 2 | BSPED2023

Introduction of under-fives type 1 diabetes clinic improves glycaemic control through rapid access to automated insulin delivery systems

Balagamage Chamila , Pemberton John , Collins Louise , Krone Ruth

Introduction: Achieving glycaemic targets for young children with type 1 diabetes (T1D) is challenging due to rapidly changing physiology and behavioural patterns. An under-fives specialised multidisciplinary clinic (U5-MDT) was implemented in January 2022 due to poorer glycaemic control in this group compared to the rest of the clinic cohort. The U5-MDT aimed to optimise glycaemic control through access to technology while providing family support.<p clas...

ea0095p63 | Obesity 1 | BSPED2023

The positive effect of liraglutide treatment on body mass index and metabolic profile in adolescents with obesity

Atiq Elham , Apperley Louise , Parkinson Jennifer , Senniappan Senthil

Introduction: Obesity is a chronic and complex disease which is considered as one of the major health challenges with short- and long-term health consequences. Childhood obesity is defined as having a body mass index (BMI) at or above the 95th percentile for age and gender after two years of age. The glucagon-like peptide-1 (GLP-1) receptor agonist, liraglutide, is proven to promote weight reduction when used at a higher dose of 3.0 mg once daily. This study a...

ea0052p01 | (1) | UKINETS2017

Genetics and diagnostic characterisation of bladder paragangliomas

Rafique Shaina , Surendran Aarthi , Joshi Mamta , Breen Louise , Velusamy Anand , Izzat Louise , McGowan Barbara , Powrie Jake , Carroll Paul V

Bladder Paragangliomas (PGLs) are a rare manifestation of sympathetic chain PGLs and occur in prone patients with SDH mutation.They often display an aggressive phenotype with metastatic disease and require long-term follow up. SDHB immunostaining plays a significant role in initial risk stratification and facilitating appropriate genetic testing. We report four cases illustrating diagnostic management and outcome issues in this rare neuroendocrine pathology; two with SDHB muta...